Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2063)	1/16/2008 1:22:45 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

INGN still hasn't given any information about its Advexin EMEA, BLA or MAA, but the stock has been up 9.23% & still is up 7.21% with volume now > 100Ks, approaching its ADV. bigcharts.marketwatch.com The stock needs to close above $2.90 in order to test the resistance from the $3.10 to the $3.25 level. In spite that it came down 27% in the last month, the short ratio is still around 40x the ADV.<g> If INGN can come out with some positive news, there will probable be a good amount of short covering.<g> bigcharts.marketwatch.com Bernard